Status:
RECRUITING
Using the Chinese Indigenization FS Scale in the Diagnosis of Fibromyalgia： Specificity and Sensitivity in Clinical Practice
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Collaborating Sponsors:
Hebei Provincial Hospital of Traditional Chinese Medicine
BAODING NO.1 HOSPITAL OF TCM
Conditions:
Fibromyalgia
Eligibility:
All Genders
18+ years
Brief Summary
This study aimed to evaluate the specificity and sensitivity of the diagnostic criteria for fibromyalgia after conducting local validation in China.
Eligibility Criteria
Inclusion
- At least 18 years of age; Patients with chronic widespread pain; Able to complete the questionnaire.
Exclusion
- Terminal patients with severe psychiatric diseases, tumors, systemic lupus erythematosus, systemic sclerosis, or other serious diseases.
Key Trial Info
Start Date :
May 21 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT06533410
Start Date
May 21 2024
End Date
May 31 2025
Last Update
October 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guang'anmen Hospital
Beijing, Beijing Municipality, China, 100053